The global tacrolimus ointment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tacrolimus ointment suppresses the immune system and the inflammation by inhibiting an enzyme (calcineurin) crucial for the multiplication of T-cells, cells that are required for activation of the immune system. Tacrolimus ointment is a drug that is applied to the skin for the treatment of atopic dermatitis (eczema). Further, atopic dermatitis is a chronic (long-lasting) disease of the skin in which the skin becomes inflamed, causing itchiness, redness, swelling, cracking, weeping, crusting, and scaling. Moreover, tacrolimus ointment is available in two strengths such as 0.03% and 0.1%. 0.03% is suitable for use by children and 0.1% is suitable for use by adults. 

Some major players in the market include Astellas Pharma Inc., GlaxoSmithKline plc, and Glenmark Pharmaceuticals Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2020, Glenmark Pharma has announced that the company has received final approval from the US health regulator Food and Drug Administration (FDA) for Tacrolimus Ointment, 0.1%, the generic version of Protopic Ointment, 0.1%, of Leo Pharma AS. In addition, according to IQVIATM sales data for the 12-month period ending February 2018, the Protopic Ointment, 0.1% market achieved annual sales of approximately $109.0 million.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Product Type 
• By Application

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- Astellas Pharma Inc., GlaxoSmithKline plc, and Glenmark Pharmaceuticals Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Tacrolimus Ointment Market Report by Segment

By Product Type 

• Ointment 0.1
• Ointment 0.03

By Application

• Adults
• Kids

Global Tacrolimus Ointment Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa